Postoperative penile prosthesis pain: is it worse in diabetic patients?
- 23 April 2020
- journal article
- research article
- Published by Springer Nature in International Journal Of Impotence Research
- Vol. 33 (3) , 286-290
Abstract
Inflatable penile prosthesis (IPP) surgery is an effective, safe and satisfactory treatment option for medication-refractory erectile dysfunction. Postoperative complications include infection, mechanical failure, erosion, and pain. Current literature suggests the need for a better approach to postoperative pain management after IPP surgery. Clinical studies have demonstrated that postoperative pain is different in diabetic patients. We sought to determine if there is a difference in pain after IPP placement in diabetics. This is a single-institution retrospective review. The main outcome measure was the number of 30-day postoperative visits for pain. The secondary outcome included differences in how pain was managed. The top HbA1c quartile was compared with the other HbA1c quartiles. Diabetes was present in 92 (54.4%) patients and 96% of these had HbA1c > 8. Significant postoperative pain was more common in patients with HbA1c > 8 (41% vs 13%, p = 0.047) and resulted in more unplanned visits (27% vs 11%, p = 0.042). Patients with HbA1c > 8 with significant postoperative pain were more likely to be managed with opioids and gabapentin (30% vs 14%, p = 0.05). There were no statistical differences in age between diabetics and non-diabetics (mean 59 vs 61, p = 0.193). Hispanic and African-American patients represented 87% of the poorly controlled diabetics compared with only 13% of white patients (p < 0.001). Poorly controlled diabetics had more medical comorbidities (p < 0.001). On logistic regression, a HbA1c > 8 was predictive of an unplanned visit for pain with an OR of 2.83 (p = 0.04). Significant pain after IPP surgery was higher in diabetics with HbA1c > 8, which resulted in more unplanned 30-day postoperative visits. Patients with significant postoperative pain were managed with a combination of opioids and gabapentin. Future studies are required to optimize pain management in diabetics following IPP placement.Keywords
This publication has 14 references indexed in Scilit:
- Factors Associated With Opioid Use in Long-term Cancer SurvivorsJournal of Pain and Symptom Management, 2019
- Diagnosis and management of sensory polyneuropathyBMJ, 2019
- Penile Prosthesis Complications: Planning, Prevention, and Decision MakingSexual Medicine Reviews, 2019
- Perspectives of pain in patients with type 2 diabetesExpert Review of Endocrinology & Metabolism, 2019
- Comorbidity effect on speed of recovery after arthroscopic rotator cuff repairJSES Open Access, 2018
- Barriers to Chronic Pain Measurement: A Qualitative Study of Patient PerspectivesPain Medicine, 2015
- High Patient Satisfaction After Inflatable Penile Prostheses Implantation Correlates with Female Partner SatisfactionThe Journal of Sexual Medicine, 2013
- Evidence‐based Guideline: Treatment of Painful Diabetic NeuropathyPM&R, 2011
- Guidelines on Male Sexual Dysfunction: Erectile Dysfunction and Premature EjaculationEuropean Urology, 2010
- CHAPTER 1: THE MANAGEMENT OF ERECTILE DYSFUNCTION: AN AUA UPDATEJournal of Urology, 2005